In adults, the use of TORADOL (ketorolac tromethamine) ORAL is only indicated as continuation therapy to IV or IM dosing of ketorolac tromethamine. Transition from IV or IM dosing of ketorolac tromethamine (single- or multiple-dose) to multiple-dose TORADOL (ketorolac tromethamine) ORAL: ...
IV Administration In normal adult subjects (n=37), the total clearance of 30 mg IV-administered ketorolac tromethamine was 0.030 (0.017-0.051) L/h/kg. The terminal half-life was 5.6 (4.0-7.9) hours. (SeeKinetics in Special Populationsfor use of IV dosing of ketorolac tromethamine in pediatr...
Maximum duration of ketorolac therapy should not exceed 5 days for tablets, or 2 days for continuous daily dosing with parenteral formulations.• Mild to moderate pain • Rheumatoid arthritis • Osteoarthritis • Ankylosing spondylitis • Primary dysmenorrhea ...